Why Is Adamis Pharmaceuticals Corp (NASDAQ:ADMP) On The Move?

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) is seeing a little pop after news.

Market Action

As of 11.52, ADMP stock gained by 5.16% at $0.75. More than 1.70 million shares have been traded hands. ADMP opened at .002 and has traded between .0021 and .0026.

ADMP Issues News

Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA for the Treatment of Opioid Overdose

  • ADMP announced that the New Drug Application (NDA) was resubmitted to the U.S. Food and Drug Administration (FDA) for ZIMHI™, a naloxone injection product candidate intended for the treatment of opioid overdose.

“Based on FDA feedback received during our Type A meeting in April, we have resubmitted our NDA for ZIMHI, which I am confident fully addresses the issues raised in the November 13, 2020 Complete Response Letter,” said Dr. Dennis J. Carlo, President and Chief Executive Officer of Adamis Pharmaceuticals.

 “We are committed to working collaboratively with the agency as it conducts its review of the resubmitted NDA. I continue to believe the availability of additional naloxone products, especially our higher dose intramuscular injection product, which has definite advantages over the two approved intranasal products, could potentially save thousands of lives.”

Trader Notes

Share Information

SHARE FLOAT (%)147.32 M (98.95%)

Recent Stock Performance

5-DAY PERF.+2.73%
1-MONTH PERF.+2.24%
3-MONTH PERF.-49.98%
6-MONTH PERF.+82.90%
YTD PERF.+53.64%
1-YEAR PERF.+39.78%

Moving Averages

+/- EMA(20)0.77 (-2.60%)
+/- SMA(50)0.87 (-13.79%)
+/- SMA(200)0.86 (-12.79%)

Pivot Points

NameS3S2S1Pivot PointsR1R2R3

Technical Indicators

CCI20-81.7150SellChaikin Money Flow0.0389Neutral
MACD-0.0680SellMoney Flow Index57.8446Sell
STOCH (14,3)12.0244OverSoldSTOCH RSI0.8249OverBought
UO33.1167SellWilliams %R-87.9756OverSold

Related Posts

About The Author